Antipsychotic Medication Prescribing Trends in Children and Adolescents

Journal of Pediatric Health Care

Volumn 26, Issue 2, 2012, Pages 139-145

  Harrison, Joyce Nolan ^a   Cluxton Keller, Fallon ^b   Gross, Deborah ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Antipsychotics in children; Child mental illness; Prescribing trends

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL PRACTICE; DRUG ADMINISTRATION; FEMALE; HUMAN; MALE; MENTAL DISEASE; NURSING; OFF LABEL DRUG USE; PRESCRIPTION; STANDARD; STATISTICS;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; CHILD; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; OFF-LABEL USE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84857167127     PISSN: 08915245     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedhc.2011.10.009     Document Type: Article

References (43)

1. American Academy of Child and Adolescent Psychiatry. (2011). AACAP practice parameter for the use of atypical antipsychotic medications in children and adolescents. Retrieved from http://www.aacap.org/galleries/PracticeParameters/Atypical_Antipsychotic_Medications_Web.pdf.
2. American Academy of Pediatrics & American Academy of Child & Adolescent Psychiatry. (2009). Improving mental health services in primary care: Reducing administrative barriers to access and collaboration. Retrieved from http://practice.aap.org/content.aspx?aid=2275.pdf.
3. Arnold L.E., Farmer C., Kraemer H.C., Davies M., Witwer A., Chuang S., Swiezy N.B., et al. Moderators, mediators, and other predictors of risperidone response in children with Autistic Disorder and irritability. Journal of Child and Adolescent Psychopharmacology 2010, 20:83-93.
4. Biederman J., Mick E., Hammerness P., Harpold T., Aleardi M., Dougherty M., Wozniak J. Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age children. Biological Psychiatry 2005, 58:589-594.
5. Burns B.J., Phillips S.D., Wagner H.R., Barth R.P., Kolko D.J., Campbell Y., Landsverk J. Mental health need and access to mental health services by youths involved in child welfare: A national survey. Journal of the American Academy of Child and Adolescent Psychiatry 2004, 43:960-970.
6. Bussing R., Gary F.A., Mason D.M., Leon C.M., Sinha K., Garvan C.W. Child temperament, ADHD, and caregiver strain: Exploring relationships in an epidemiological sample. Journal of the American Academy of Child & Adolescent Psychiatry 2003, 42(2):184-192.
7. Case B.G., Olfson M., Marcus S.C., Siegel C. Trends in inpatient mental health treatment in children and adolescents in US community hospitals between 1999-2000. Archives of General Psychiatry 2007, 64:89-96.
8. Centers for Disease Control and Prevention & National Center for Health Statistics. (2007). National Survey of Children's Health, 2007. Retrieved from http://www.cdc.gov/nchs/slaits/nsch.htm.
9. Crystal S., Olfson M., Huang C., Pincus H., Gerhard T. Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs 2009, 28:770-781.
10. Currie J., Stabile M. Child mental health and human capital accumulation: The case of ADHD. Journal of Health Economics 2006, 25:1094-1118.
11. De Hert M., Dobbelaere M., Sheridan E.M., Cohen D., Correll C.U. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: A systematic review of randomized, placebo-controlled trials and guidelines for clinical practice. European Psychiatry 2011, 26(3):144-158.
12. DelBello M.P., Chang K., Welge J.A., Adler C.M., Rana M., Howe M., Strakowski S.M., et al. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disorders 2009, 11(5):483-493.
13. Delbello M.P., Schwiers M.L., Rosenberg H.L., Strakowski S.M. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(10):1216-1223.
14. Egger H. A perilous disconnect: Antipsychotic drug use in very young children. Journal of the American Academy of Child Adolescent Psychiatry 2010, 49(1):3-6.
15. Findling R.L., Aman M.G., Eerdekens M., Derivan A., Lyons B. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. American Journal of Psychiatry 2004, 161(4):677-684.
16. Findling R.L., McNamara N.K., Gracious B. Antipsychotic agents: Traditional and atypical. Pediatric psychopharmacology: Principles and practice 2003, 328-340. Oxford University Press, Oxford, UK. A. Martin, L. Scahill, D. Charney, J. Lechman (Eds.).
17. Findling R.L., Nyilas M., Forbes R.A., McQuade R.D., Jin N., Iwamoto T., Chang K., et al. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: A randomized, double-blind, placebo-controlled study. Journal of Clinical Psychiatry 2009, 70(10):1441-1451.
18. Gleason M.M., Egger H.L., Emslie G.J., Greenhill L.L., Kowatch R.A., Lieberman A.F., Zeanah C.H., et al. Psychopharmacological treatment for very young children: Contexts and guidelines. Journal of the American Academy of Child Adolescent Psychiatry 2007, 46:1532-1572.
19. Haas M., Delbello M.P., Pandina G., Kushner S., Van Hove I., Augustyns I., Kusumakar V., et al. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: A randomized, double-blind, placebo-controlled study. Bipolar Disorders 2009, 11(7):687-700.
20. International Society of Psychiatric Mental Health Nurses. (2010). The educational preparation of advanced practice nurses to address the mental health needs of children and adolescents. Retrieved from http://www.ispn-psych.org/docs/EduPrepForChildren.pdf.
21. Larson K., Russ S.A., Kahn R.S., Halfon N. Patterns of comorbidity, functioning, and service use for US children with ADHD, 2007. Pediatrics 2011, 127(3):462-470.
22. Manning S.E., Davin C.A., Barfield W.D., Kotelchuck M., Clements K., Diop H., Smith L.A., et al. Early diagnoses of autism spectrum disorders in Massachusetts birth cohorts, 2001-2005. Pediatrics 2011, 127(6):1043-1051.
23. McCracken J.T., McGough J., Shah B., Cronin P., Hong D. Risperidone in children with autism and serious behavioral problems. New England Journal of Medicine 2002, 347(5):314-321.
24. McMillen J.C., Zima B.T., Scott L.D., Auslander W.F., Munson M.R., Ollie M., Spitznagel E.L. Prevalence of psychiatric disorders among older youths in the foster care system. Journal of the American Academy of Child and Adolescent Psychiatry 2005, 44:88-95.
25. Meadows T., Valleley R., Haack M.K., Thorson R., Evans J. Physician " costs" in providing behavioral health in primary care. Clinical Pediatrics 2011, 50(5):447-455.
26. Medicaid Medical Directors Learning Network & Rutgers Center for Education and Research on Mental Health Therapeutics. (2010). Antipsychotic medication use in Medicaid children and adolescents: Report and resource guide for a 16-state study (MMDLN/Rutgers CERTs Publication No. 1). Retrieved from http://rci.rutgers.edu/NCSeap/MMDLNAPKIDS.html.
27. Morrato E.H., Nicol G.E., Maahs D., Druss B.G., Hartung D.M., Valuck R.J., Newcomer J.W., et al. Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatric and Adolescent Medicine 2010, 164(4):344-351.
28. Moore, S. (2009, August 9). Mentally ill strain juvenile system. The New York Times. Retrieved from http://www.nytimes.com/2009/08/10/us/10juvenile.html.
29. Muris P., Meesters C., Morren M., Moorman L. Anger and hostility in adolescents: Relationships with self-reported attachment styles and perceived parenting rearing styles. Journal of Psychosomatic Research 2004, 57:257-264.
30. Preventing mental, emotional and behavioral disorders among young people 2009, National Research Council & Institute of Medicine, National Academy of Sciences, Washington, DC.
31. Olfson M., Crystal S., Huang C., Gerhard T. Trends in antipsychotic drug use by very young, privately insured children. Journal of the American Academy of Child Adolescent Psychiatry 2010, 49:13-23.
32. Pathak P., West D., Martin B.C., Helm M.E., Henderson C. Evidence-based use of second generation antipsychotics in a state Medicaid pediatric population 2001-2005. Psychiatric Services 2010, 61:123-129.
33. Sadock B.J., Sadock V.A. Synopsis of psychiatry 2003, Lippincott Williams & Wilkins, Philadelphia, PA. 9th ed.
34. Shore J.H., Brooks E., Savin D., Orton H., Grigsby J., Manson S.M. Acceptability of telepsychiatry in American Indians. Telemedicine and e-health 2008, 14:461-466.
35. Spaulding R., Belz N., DeLurgio S., Williams A.R. Cost savings of telemedicine utilization for child psychiatry in a rural Kansas community. Telemedicine and e-health 2010, 16:867-871.
36. Thomas C.R., Holzer C.E. The continuing shortage of child and adolescent psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:1023-1031.
37. Tohen M., Kryzhanovskaya L., Carlson G., Delbello M., Wozniak J., Kowatch R., Biederman J., et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. American Journal of Psychiatry 2007, 164(10):1547-1556.
38. United States Department of Health & Human Services. (2000). Mental health: A report of the Surgeon General. Washington, DC: US Government Printing Office. Retrieved from http://www.surgeongeneral.gov/library/mentalhealth/home.html.
39. Zito J.M., Derivan A.T., Kratochvil C.J., Safer D.J., Fegert J.M., Greenhill L.L. Off-label psychopharmacologic prescribing for children: History supports close clinical monitoring. Child and Adolescent Psychiatry Mental Health 2008, 2(1):24.
40. Zito J.M., Safer D.J., de Jong-van den Berg L., Janhsen K., Fegert J.M., Gardner J.F., Valluri S.C., et al. A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatry and Mental Health 2008, 2:26.
41. Zito J.M., Safer D.J., dosReis S., Gardner J.F., Boles M., Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000, 283(8):1025-1030.
42. Zito J.M., Safer D.J., Sai D., Gardner J.F., Thomas D., Coombes P., Mendez-Lewis M., et al. Psychotropic medication patterns among youth in foster care. Pediatrics 2008, 121:157-163.
43. Zito J.M., Safer D.J., Valluri S., Garner J.F., Korelitz J.J., Mattison D.R. Psychotherapeutic medication prevalence in Medicaid-insured preschoolers. Journal of Child and Adolescent Psychopharmacology 2007, 17:195-203.